Globus Medical Reports Full Year and Fourth Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% as AI buildout costs, Fed rate outlook weigh
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Leerink Partners Reiterates Outperform Following Globus Medical's (GMED) Strong 4Q
February 25, 2016 7:26 AM ESTLeerink Partners maintained an Outperform rating on Globus Medical (NYSE: GMED), and cut the price target to $29.00 (from $32.00), following the company's 4Q earnings report. Revenue of ~$142.6M was in line with the January preannouncement and ~$4M above the Street. GMED also delivered... More
Globus Medical (GMED) Tops Q4 EPS by 9c
February 24, 2016 4:51 PM ESTGlobus Medical (NYSE: GMED) reported Q4 EPS of $0.39, $0.09 better than the analyst estimate of $0.30. Revenue for the quarter came in at $142.6 million versus the consensus estimate of $141.2 million.
For earnings history and earnings-related data on Globus Medical (GMED) click here.
... More